Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

Hormone replacement therapy, or HRT, was the first menopause treatment available to women, approved by the FDA in 1941. It ...

Triple-positive breast cancer involves tumors positive for estrogen, progesterone, and HER2 receptors, affecting treatment decisions and strategies. Diagnosis includes imaging and biopsy to confirm ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

Learn what to expect with chemotherapy and hormone therapy, as well as managing fears of recurrence and embracing life after cancer. Today on the pod, we're continuing the conversation around breast ...

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited ...

Hormone replacement therapy (HRT) does not increase breast cancer risk in BRCA1/BRCA2 carriers, with estrogen-alone formulations showing a lower risk. The study used a matched-pair design to control ...

Ovarian cancer tends to be resistant to hormone therapy, even when it should theoretically respond. Wistar Institute ...

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. Researchers discovered that women treated ...

Hormone therapy can affect collagen, hydration, and breakouts during menopause. Dermatologists explain the real skin benefits ...

After decades when menopausal women were steered away from hormone therapy due to breast cancer concerns, new evidence shows it may be right for some.

Joanne Graham, 50, was diagnosed with breast cancer in July 2024 after discovering a line across her nipple whilst on holiday in Spain. Following a mastectomy and hormone treatment, the personal ...